These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26970341)

  • 1. An early look at the Organ Procurement and Transplantation Network explant pathology form data.
    Harper AM; Edwards E; Washburn WK; Heimbach J
    Liver Transpl; 2016 Jun; 22(6):757-64. PubMed ID: 26970341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
    Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
    Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form.
    Mehta N; Dodge JL; Roberts JP; Hirose R; Yao FY
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28881064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria.
    Ecker BL; Hoteit MA; Forde KA; Hsu CC; Reddy KR; Furth EE; Siegelman ES; Habibollahi P; Ben-Josef E; Porrett PM; Abt PL; Shaked A; Olthoff KM; Levine MH
    Transplantation; 2018 Apr; 102(4):648-655. PubMed ID: 29319629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time.
    Mehta N; Dodge JL; Grab JD; Yao FY
    Hepatology; 2020 Mar; 71(3):943-954. PubMed ID: 31344273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Characteristics and Long-Term Outcome of Incidental Hepatocellular Carcinoma After Orthotopic Liver Transplant.
    Mourad MM; Algarni A; Aly MA; Gunson BK; Mergental H; Isaac J; Muiesan P; Mirza D; Perera MT; Bramhall SR
    Exp Clin Transplant; 2015 Aug; 13(4):333-8. PubMed ID: 26295183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.
    Pomfret EA; Washburn K; Wald C; Nalesnik MA; Douglas D; Russo M; Roberts J; Reich DJ; Schwartz ME; Mieles L; Lee FT; Florman S; Yao F; Harper A; Edwards E; Freeman R; Lake J
    Liver Transpl; 2010 Mar; 16(3):262-78. PubMed ID: 20209641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waiting time and explant pathology in transplant recipients with hepatocellular carcinoma: a novel study using national data.
    Bittermann T; Hoteit MA; Abt PL; Forde KA; Goldberg D
    Am J Transplant; 2014 Jul; 14(7):1657-63. PubMed ID: 24902486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical profile and liver explant findings in patients with and without pretransplant downstaging for hepatocellular carcinoma.
    Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2399-402. PubMed ID: 23026605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
    Battula N; Reichman TW; Amiri Y; Carmody IC; Galliano G; Seal J; Bugeaud E; Bohorquez H; Bruce D; Cohen A; Loss GE
    Liver Transpl; 2017 Mar; 23(3):299-304. PubMed ID: 28026108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K; Timmins K; Brensinger C; Furth EE; Rattan S; Sun W; Rosen M; Soulen M; Shaked A; Reddy KR; Olthoff KM
    Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiological-histopathological discordance in patients transplanted for HCC and its impact on post-transplant outcomes.
    Mohamed IB; Ismail MS; El Sabagh A; Afifi Abdelwahab AM; Polychronopoulou E; Kuo YF; Hassan M; Goss JA; Kanwal F; Jalal PK
    Cancer Med; 2023 Jul; 12(14):15011-15025. PubMed ID: 37326440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models.
    Costentin CE; Amaddeo G; Decaens T; Boudjema K; Bachellier P; Muscari F; Salamé E; Bernard PH; Francoz C; Dharancy S; Vanlemmens C; Radenne S; Dumortier J; Hilleret MN; Chazouillères O; Pageaux GP; Calderaro J; Laurent A; Roudot-Thoraval F; Duvoux C;
    Liver Int; 2017 May; 37(5):717-726. PubMed ID: 28199760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database.
    Mehta N; Dodge JL; Roberts JP; Yao FY
    Am J Transplant; 2018 May; 18(5):1206-1213. PubMed ID: 29068145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection.
    Court CM; Harlander-Locke MP; Markovic D; French SW; Naini BV; Lu DS; Raman SS; Kaldas FM; Zarrinpar A; Farmer DG; Finn RS; Sadeghi S; Tomlinson JS; Busuttil RW; Agopian VG
    Liver Transpl; 2017 Sep; 23(9):1123-1132. PubMed ID: 28688158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of organ procurement and transplant network (OPTN)/united network for organ sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma.
    Fowler KJ; Karimova EJ; Arauz AR; Saad NE; Brunt EM; Chapman WC; Heiken JP
    Transplantation; 2013 Jun; 95(12):1506-11. PubMed ID: 23778569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.